Bayer Tag

The US biotech company Dendreon, which reportedly has put itself up for sale, is unlikely to be the subject of a bidding war, suggests Credit Suisse analyst Lee Kalowski, given the commercial and financial struggles the company is facing. Dendreon, which makes the prostate cancer treatment...